Search
for
Sort by
Research 61–90 of 1000+
- Clinical and Histopathological Features of Hair Loss in 17 Japanese Patients With Hematologic Disorders Following Hematopoietic Stem Cell Transplantation and Chemotherapy: A Case Series.
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- Alopecia - the search for novel agents continues
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Impact of Chemotherapeutic Drug on People living with Cancer
- In Vivo Evaluation of<i>Eclipta alba</i>Extract as Anticancer and Multidrug Resistance Reversal Agent
- Synthesis of minoxidil conjugates and their evaluation as HL-60 differentiation agents
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- Genotoxic Agents: An Unexpected Effect on Healthy Epithelia
- Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood
- Drug-Induced Hair Loss and Hair Growth
- DRUG‐ASSOCIATED ALOPECIA
- Drug-induced acne
- Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases
- Postmenopausal Alopecia (Hair Loss)
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Recent Advances in the Structural Design of Photosensitive Agent Formulations Using “Soft” Colloidal Nanocarriers
- Necrosis of the donor site after hair restoration with follicular unit extraction (FUE): A case report
- Madarosis
- Cutaneous Manifestations of Chronic Kidney Disease: A Narrative Review
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- Hair Follicle Transit-Amplifying Cells Phagocytose Dead Cells after Radiotherapeutic and Chemotherapeutic Injuries for Timely Regeneration
- Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological Agents
- Effects of cytokines, anti-cancer agents and cocarcinogen on DNA synthesis in hair bulb cells
- Synthesis and biological activity evaluation of new isatin-gallate hybrids as antioxidant and anticancer agents (in vitro) and in silico study as anticancer agents and coronavirus inhibitors
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Cytotoxicity of bendamustine, alone and in combination with novel agents, toward adult T-cell leukemia cells
- Platinum-Induced Peripheral Neuropathy (PIPN): ROS-Related Mechanism, Therapeutic Agents, and Nanosystems
- Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?
- ZnO@PDA@Ag Nanocomposite-Mediated Delivery of 9-Bromonoscapine, an Anticancer Agent, for Enhanced Lung Cancer Therapy